Key Takeaways
- RKLB shares currently trade at $82.83, representing a 57% decline from the $151 all-time high
- Wall Street analysts maintain a “Moderate Buy” consensus with a $110.29 average target price
- First quarter fiscal 2026 revenue reached $200.35 million, representing 63.4% year-over-year growth
- The company recently won approximately $663 million in contracts from the U.S. Space Force
- Company insiders have divested $362.8 million in shares during the previous three-month period
Shares of Rocket Lab (RKLB) began Monday’s trading session at $82.83, marking a substantial 57% retreat from the $151 peak achieved in June. Despite this significant pullback, Wall Street analysts remain optimistic about the space company’s prospects. The average analyst price target stands at $110.29, suggesting potential upside of approximately 49% from present trading levels.
Analyst sentiment leans positive with a “Moderate Buy” consensus. The breakdown includes three Strong Buy recommendations, thirteen Buy ratings, five Hold opinions, and a single Sell rating. Morgan Stanley maintained its “Overweight” stance on the stock in July, while New Street Research established a $150 target back in May.
First quarter fiscal 2026 financial results showed revenue of $200.35 million, marking 63.4% year-over-year expansion and surpassing analyst projections of $189.65 million. The per-share loss of $0.07 aligned precisely with Wall Street expectations.
The contract pipeline presents a compelling narrative. Rocket Lab signed 31 launch agreements during Q1 alone, exceeding the total contracts secured throughout the entire 2025 calendar year. The company’s total backlog climbed to $2.2 billion, representing 108% growth compared to the prior-year period.
Adjusted EBITDA posted a loss of $11.8 million, significantly outperforming the consensus estimate calling for a $26 million loss. Following these results, no fewer than seven analysts boosted their price objectives.
Major Government Contracts Provide Momentum
Recent contract victories deserve attention. Rocket Lab landed a $397 million agreement with the U.S. Space Force encompassing development, launch operations, and management of sophisticated flat satellites utilizing its forthcoming Neutron launch vehicle. An additional $266 million Space Force contract encompasses 12 suborbital missions plus up to six optional launches, with the initial mission scheduled before year-end.
Combined, Rocket Lab has captured roughly $663 million in recent Space Force awards. The Neutron rocket, critical to executing the larger contract, remains in development and has not yet completed a test flight.
The company also successfully executed its 92nd Electron launch and 13th mission of 2026, placing a satellite into orbit for returning customer iQPS.
Significant Challenges Remain
Profitability remains elusive. The company recorded a $45 million net loss during Q1, and analysts project a full-year per-share loss of $0.26. The stock’s price-to-sales multiple of 53 significantly exceeds the technology sector average near 7.
Insider transaction activity warrants monitoring. During the past three months, company insiders have liquidated 3.85 million shares valued at approximately $362.8 million. Senior Vice President Arjun Kampani divested 88,000 shares in June at an average sale price of $107.98. A portion of these transactions related to tax liabilities associated with equity compensation vesting.
Institutional ownership accounts for 71.78% of outstanding shares. PensionDanmark expanded its position by 224.2% during Q2, purchasing 28,358 additional shares to reach a total holding of 41,008 shares valued at roughly $4.17 million.
With a beta coefficient of 2.60, the stock exhibits high volatility. The 52-week trading range spans from $37.57 to $151.00.
Rocket Lab will release Q2 financial results following Monday’s market close on August 10. Market participants will focus on revenue trajectory, Neutron development progress, and management commentary regarding the pathway to achieving profitability.


